0.1 mmol scale using Fmoc chemistry on 2-chlorotrityl (2CT) resin preloaded with Ala (0.6 mmol/g). Factory settings were used for all coupling and deprotection cycles. Asymmetrically protected amino acids were used as 0.2 M solutions in DMF, with amino acid subunits being coupled using HATU as the activator and DIPEA as the activator base and heated to 70 °C for 5 min. Fmoc residues were deprotected using a 20 % solution of piperidine in DMF. An initial deprotection was performed at 70 °C for 0.5 min, followed by an additional deprotection at 70 °C for 3 min. Upon completion of synthesis, the peptide resin was washed with DCM (3 x 5 mL) in a glass-fritted filter funnel and dried under vacuum suction for 15 min. Dried peptide resin was transferred to a vial containing TFA:TIPS:H 2 O (95:2.5:2.5, 10 mL) and heated at 30 °C for 1.5 h with periodic manual shaking. The resin beads were then removed by filtration through glass wool and the filtrate was concentrated in vacuo. Et 2 O (5 mL) was added to precipitate crude peptide and the resulting suspension transferred to 2 mL centrifuge tubes. The tubes were centrifuged for 1 min using a microcentrifuge and the liquid decanted. Pellets were resuspended in Et 2 O (1 mL), vortexed, centrifuged and the liquid decanted to yield crude peptide pellets.
III.
Purification and analysis of peptides 
Pseudomonas pseudoalcaligenes
Isolated from sewage contaminated water (Saida, Lebanon). Ceftriaxone
VI. Haemolytic activity assays
A 96-well plate was first prepared to contain phosphate-buffered saline (PBS) solutions (100 μL) of tridecaptin analogues 1 -8 (200 μg/mL) (experiments run in triplicate). 0.1 % Triton X-100 (100 μL) was used as a positive control, while PBS (100 μL) was used as a blank. After the plate had been prepared, defibrinated horse blood (0.5 mL, VWR International) was diluted with phosphate-buffered saline (9.5 mL) and gently shaken. The resulting mixture was centrifuged (5600 rpm, 5 min) using a Thermo Scientific Heraeus Labofuge 200 centrifuge and the supernatant carefully removed. This process was repeated three more times to remove any free hemoglobin. The resulting erythrocyte pellet was gently resuspended in 9.5 mL of PBS. Aliquots of the resulting mixture (100 μL) were added to the appropriate wells on the 96-well plate using a multichannel pipette and the plate incubated at 37 °C for 30 min. Table S1 . Peptide number, name, chemical formula, exact mass, mass found and overall yield for peptides 1 -8. Fig. S1 . HPLC trace showing the reinjection of purified Oct-TriA 1 (1). The peptide eluted as a single peak at 12.53 min using the HPLC method outlined in part III. 
